Several classes of compounds (thioureas, ureas, beta-glucosides, sulfonamides, and cyclic peptides) show enhanced binding affinity and selectivity at somatostatin subtype 4 receptors (sst4). Pharmacophore models have recently been proposed to explain receptor subtype selectivity. The chemistry and therapeutic potential of sst4 ligands will be the subject of this review.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/138955707780059880 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!